XRP News Today; Cardano Price Prediction & What Is Backed As The Best Crypto To Buy Now?

來源 Cryptopolitan

XRP continues to dominate headlines as traders monitor key resistance levels, while fresh Cardano price prediction reports suggest ADA could face more hurdles in the months ahead. 

Despite the buzz around these established tokens, analysts are pointing to Remittix, a new contender gaining momentum as the best crypto to buy now. With real-world use cases and growing adoption, this rising project is capturing serious investor attention.

XRP News Shows Whale Accumulation Remains Strong

XRP has been in the spotlight after a $600 million Ripple transfer sparked uncertainty among traders, leaving the market cautious despite recent bullish signs. At the time of writing, the XRP Price today is $2.88, holding key support at $2.85 after briefly testing $2.94. While whale accumulation has added confidence, profit-taking by short-term holders is limiting upside momentum. 

Analysts warn that unless XRP breaks above $3.10, the Ripple Price Prediction remains fragile. Technical indicators like RSI and MACD suggest easing selling pressure, but the risk of another pullback lingers. In the midst of this, Remittix is quietly emerging as a safe haven in the PayFi sector, drawing attention as traders hedge against volatility in XRP.

Cardano Price Suggests Slow Momentum Ahead

The latest Cardano price has put ADA back in focus, with experts warning the token could slip under $0.50 if momentum fails to return. While the ADA Price today holds around $0.84, many traders see Cardano’s research-first approach as too slow compared to rivals like Solana.

Recent Cardano news highlights ecosystem growth and consistent staking rewards. However, excitement is fading. Without a new catalyst, the Cardano price prediction remains cautious, leaving investors to question whether ADA can keep pace in 2025.

Investors Call Remittix The Best Crypto To Buy Now

Remittix is quickly being highlighted as one of the best cryptos to buy now thanks to its practical use case in payments. Unlike speculative projects, Remittix connects crypto directly to fiat across 30+ currencies, enabling smooth, low-cost international transfers. 

Remittix is backed by stablecoins and secured by smart contracts, and this allows the platform to ensure reliable and efficient cross-border transactions. Support for Ethereum and Binance Smart Chain expands its reach, positioning Remittix as a serious competitor to legacy remittance solutions.

  • Remittix Wallet beta testing launches September 15th, 2025
  • $20M milestone reached with BitMart confirmed as the first CEX listing
  • Over $24.7M raised with LBank announced as another exchange partner
  • Smart contract security ensures transparency and faster settlements

With over 653 million tokens sold at $0.1050, Remittix has already secured major traction. The combination of utility and adoption makes RTX stand out from XRP and Cardano happenings, proving it could be the best crypto to buy right now.

Discover the future of PayFi with Remittix by checking out their project here:

Website: https://remittix.io/ 

Socials: https://linktr.ee/remittix 

$250K Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway

免責聲明:僅供參考。 過去的表現並不預示未來的結果。
placeholder
黃金七連漲終結!是上車機會還是牛市拐點?​2025年9月4日,瘋狂上漲的黃金終於「喘了口氣」——國際金價在連續七日創新高後回檔0.38%,收報3545.78美元/盎司。很多投資人一邊糾結是不是該獲利了結,一邊又怕錯過後續行情。
作者  投資-槓把子
9 月 05 日 週五
​2025年9月4日,瘋狂上漲的黃金終於「喘了口氣」——國際金價在連續七日創新高後回檔0.38%,收報3545.78美元/盎司。很多投資人一邊糾結是不是該獲利了結,一邊又怕錯過後續行情。
placeholder
外資連5日賣超,台船(2208)股價攀升的背後,是大筆軍工訂單正在趕來台船(2208)股價近期再度上揚,從8月28日低點18.15元,一路攀升至9月8日高點27.1元,上漲幅度高達49.3%。雖然今日(9日)小幅回落,目前報價為25.65元,但受惠於優異的8月業績表現,以及潛在大單即將進帳的利多消息,台船已遭外資連續5日賣超,顯示市場對其前景的強烈期待。
作者  財富進化論
昨日 03: 12
台船(2208)股價近期再度上揚,從8月28日低點18.15元,一路攀升至9月8日高點27.1元,上漲幅度高達49.3%。雖然今日(9日)小幅回落,目前報價為25.65元,但受惠於優異的8月業績表現,以及潛在大單即將進帳的利多消息,台船已遭外資連續5日賣超,顯示市場對其前景的強烈期待。
placeholder
康霈*減重藥遭FDA一拳重擊!股價跳空跌停 賣單高掛上萬張 散戶集體出逃?​投資慧眼Insights-因減肥藥進展受阻,生技股康霈*(6919)今(10)日早盤開盤即跌停鎖死在229.5元,暴跌10%。
作者  投資指南針
12 小時前
​投資慧眼Insights-因減肥藥進展受阻,生技股康霈*(6919)今(10)日早盤開盤即跌停鎖死在229.5元,暴跌10%。
placeholder
康霈*澄清來得太遲!1.5萬張賣單說明一切:一場由減肥藥夢碎引發的踩踏遠未結束生物科技股康霈*(6919)昨日法說會拋出減肥新藥臨床試驗延期半年的消息,儘管公司火速發布聲明強調是"主動選擇推遲",卻難以掩蓋股價一日跌停鎖死、1.5萬張賣單排隊的殘酷現實。這場被市場解讀為"欲蓋彌彰"的澄清,反而揭露了生物科技股過度投機的問題本質。
作者  投資-槓把子
9 小時前
生物科技股康霈*(6919)昨日法說會拋出減肥新藥臨床試驗延期半年的消息,儘管公司火速發布聲明強調是"主動選擇推遲",卻難以掩蓋股價一日跌停鎖死、1.5萬張賣單排隊的殘酷現實。這場被市場解讀為"欲蓋彌彰"的澄清,反而揭露了生物科技股過度投機的問題本質。
placeholder
甲骨文股價狂飆近三成!雲端訂單衝4550億美元 CEO親曝:這三家下了大訂單​投資慧眼Insights-甲骨文(ORCL.US)最新一季度業績大爆發,盤後股價一度狂飆接進30%。
作者  投資指南針
7 小時前
​投資慧眼Insights-甲骨文(ORCL.US)最新一季度業績大爆發,盤後股價一度狂飆接進30%。
goTop
quote